Allgens(SH:688613) Cai Jing Wang·2025-10-20 07:35Core Insights - The project "Key New Technologies and Applications of Highly Active Bone Repair Materials," led by Huazhong University of Science and Technology and deeply involving AoJing Medical (688613.SH), has won the first prize of the China Biomaterials Society Science and Technology Award due to its originality, industry innovation, and significant clinical transformation value [1][4]. Group 1: Company Achievements - AoJing Medical has developed a series of Class III medical device products based on extensive research of natural bone tissue, utilizing a biomimetic mineralization technique that simulates the mineralization process of bone tissue in vivo [3][4]. - Since its approval for market entry in 2011, AoJing Medical's products have been clinically applied in millions of cases, significantly improving the quality of life for many patients and generating notable social and economic benefits [4]. Group 2: Technological Recognition - The award received in 2025 is a recognition of the technological leadership of AoJing Medical in the field of highly active bone repair materials, affirming the originality and international leading status of its patented technologies such as in vitro biomimetic mineralization [4]. - The project aligns with the company's core technology system, further validating the innovative value of its research and development efforts over the years [4].